AT22080T
Medicaments with cytostatic activity and use of cyclic compounds, in which the heterocyclic n-ring atoms are substituted by several glycidyl groups, in pharmaceutical compositions
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
19 members in 8 offices
Priority claims8
| Document | Office | Kind | Date |
|---|---|---|---|
| 3003356 | Germany | A | |
| 3003357 | Germany | A | |
| 3003404 | Germany | A | |
| 133080 | Austria | A | |
| 133180 | Austria | A | |
| 136580 | Austria | A | |
| 164980 | Austria | A | |
| 564480 | Austria | A |
Members19
| Document | Office | Kind | |
|---|---|---|---|
| IL62021A0 | Israel | A0 | |
| IL62021D0 | Israel | D0 | |
| AU6676181A | Australia | A | |
| DE3003356A1 | Germany | A1 | |
| DE3003357A1 | Germany | A1 | |
| DE3003404A1 | Germany | A1 | |
| EP0033503A2 | European Patent Office (EPO) | A2 | |
| JPS56122313A | Japan | A | |
| EP0033503A3 | European Patent Office (EPO) | A3 | |
| ZA81615B | South Africa | B | |
| AT370729B | Austria | B | |
| ATA564480A | Austria | A | |
| CA1172962A | Canada | A | |
| AU543383B2 | Australia | B2 | |
| CA1193547A | Canada | A | |
| EP0033503B1 | European Patent Office (EPO) | B1 | |
| AT22080TThis record | Austria | T | |
| ATE22080T1 | Austria | T1 | |
| DE3175281D1 | Germany | D1 |
Numbers
- Application
- 81100544
Titles2
- German
- ARZNEIMITTEL MIT CYTOSTATISCHER WIRKUNG SOWIE VERWENDUNG VON MEHRFACH MIT GLYCIDYLGRUPPEN SUBSTITUIERTEN N-HETEROCYCLISCHEN RINGVERBINDUNGEN IN PHARMAZEUTISCHEN ZUBEREITUNGEN.
- English
- DRUGS WITH CYSTOSTIC EFFICACY AND THE USE OF MULTIPLE GLYCIDYL GROUP SUBSTITUTED N-HETEROCYCLIC RING COMPOUNDS IN PHARMACEUTICAL PREPARATIONS.
Classification
- CPC, 2
- C07D487/04
- C07D405/06
- IPC, 7
- A61K31 415
- A61K31 335
- A61K31 505
- A61K31 515
- C07D403 06
- C07D405 06
- C07D487 04